Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000415736 | SCV000493444 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | DHTKD1: BS2 |
Labcorp Genetics |
RCV001085877 | SCV001121697 | likely benign | 2-aminoadipic 2-oxoadipic aciduria | 2024-01-30 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000415736 | SCV001470974 | likely benign | not provided | 2023-09-25 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000415736 | SCV005226919 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003970097 | SCV004789778 | likely benign | DHTKD1-related disorder | 2020-01-31 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |